Description
An L- and T-type calcium channel blocker; blocks recombinant rabbit L-type (α1Cα2/δβ1a) and human T-type (α1H) calcium channels expressed in Xenopus oocytes; blocks native L-type channels in dissociated guinea pig cardiac ventricular cells (IC50 = 2.6 nM); inhibits ET-1-induced increases in intracellular calcium in A7r5 rat vascular smooth muscle cells (ED50 = 1 nM); inhibits potassium-induced contraction of isolated dog femoral and portal veins (IC50s = 24 and 2.1 nM, respectively); lowers blood pressure in SHRs (10 mg/kg); inhibits isoproterenol-induced left ventricular hypertrophy in rats (3 mg/kg)
Formal name: 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid, 3-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl] 5-methyl ester
Synonyms: (±)-Manidipine|CV-4093|Franidipine
Molecular weight: 610.7
CAS: 89226-50-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ion Channel Modulation|Blockers||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cardiovascular System|Heart|Myocardial Contractility||Research Area|Cardiovascular System|Heart|Myocardial Hypertrophy||Research Area|Cardiovascular System|Vasculature|Vasodilation